Posts Tagged ‘clinical trial update’

50-year retrospective study

50-year retrospective study shows On-X Life Technologies’ mechanical heart valves have “the lowest incidence of valve thrombosis” Data presented at 22nd Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) AUSTIN, TX — April 4, 2014 — Privately held On-X® Life Technologies Inc., whose mechanical heart valves have been implanted in more…

Read More

On-X Heart Valve Study Results

Presented at the Society for Heart Valve Disease 7th Biennial Congress Two PROACT Abstracts Present Data Showing Patients on Low Anticoagulation Therapy Do Well with the On-X® Prosthetic Heart Valve AUSTIN, TX — June 25, 2013 — On-X® Life Technologies, Inc. (On-X LTI) announced today that two new PROACT abstracts further demonstrating the safety of…

Read More

On-X Life Technologies to Highlight

Reduced Anticoagulation Study Results, Long-Term and Patient Survival Data with the On-X heart valve at STS Meeting Interim results for PROACT Trial, two ten-year clinical research reports and several clinical reports indicating longer survival for mechanical valve patients available to surgeons at The Society of Thoracic Surgeons Meeting AUSTIN, TX – January 24, 2012 –…

Read More

Landmark Clinical Research

Research with the On-X Heart Valve in a poorly anticoagulated South African patient group to be presented at major US Heart Centers Mervyn A. Williams, M.D., of Provincial Hospital in Port Elizabeth, South Africa, to present findings showing that the On-X valve may be able to adapt to fluctuations in anticoagulation with all types of…

Read More

Highlighting 15 Years of Implant Excellence

At the EACTS meeting in Lisbon, Portugal Two ten-year clinical research reports present evidence of continuing superior performance of the On-X® Prosthetic Heart Valve in diverse European and South African patient groups AUSTIN, TX — July 26, 2011 — On-X® Life Technologies, Inc. (On-X LTI) announced today that it is highlighting two clinical studies completed…

Read More

On-X Heart Valve’s Exceptional Clinical Performance

Important Clinical Research Featuring the On-X Heart Valve to be Presented at The Biennial Meeting of the Society for Heart Valve Disease in Barcelona, Spain AUSTIN, Texas, Jun 27, 2011 (BUSINESS WIRE) — On-X(R) Life Technologies, Inc. (On-X LTI) announced today that four clinical trial reports, documenting the On-X(R) Prosthetic Heart Valve’s extraordinary performance, will be presented at the upcoming meeting of the Society for Heart Valve Disease in Barcelona, Spain being held June 25-28, 2011. The reports will include interim clinical results from the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT), which is being conducted in 36 major institutions in the United States, a comparison of the On-X heart valve with three competitive mechanical valves in Australia, a Ten-year Multiple Center European Study and a Ten-year Study in Poorly Controlled Anticoagulated Patients in South Africa

Read More
Onxlti Responsive Menu